Birds's Eye
Technicals
MovingAverage
Candlestick
PivotPoint
Fin Statements
Beta&Vols
Tech ChartsFundamental Analysis of CORONA Remedies Limited - Growth / Value Index
CORONA - Valuation Highlights
Valuation Analysis
Tremendous increasing in Book Value last 3 year
Tsr Value Index - Poor Score of 33.33
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|---|
| Price to Earning | 0 | 0 | 0 % | ||
| Price to Book | 0 | 0 | 0 % | 0 | |
| Price to Sales | 0 | 0 | 0 % | ||
| Enterprise Value to EBITDA Multiple | 0 | 0 % |
CORONA - Profitability Highlights
Profitability Analysis
Company Earning excess return
Good Return On Capital Employed of 22.28
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|---|
| Return On Equity | 0 | 24.64 | 30.82 % | 0 | |
| Return On Asset | 0 | 16.07 | 47.49 % | 0 | |
| Net Profit Margin | 0 | 12.49 | 40.01 % | 14.49 | |
| Operating Profit Margin | 0 | 16.07 | 45.50 % | 19.18 | |
| EBITDA Margin | 0 | 20.55 | 29.36 % | 22.40 |
Highlights
| Market Cap | 87474.35 M |
| Enterprise Value | 87634.35 M |
| Price/Book TTM | 0 |
| Outstanding Share | 61166.60 K |
| Float/ Outstanding Share | 0% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 0 |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 6.00 |
| Altman Z Score | 18.38 |
| Sloan Ratio | 0.0460 |
CORONA - Growth Highlights
Growth Analysis
Tsr Growth Index - Excellent Score of 95.00
YoY Net Margin Jump by 40.01%
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | NA | 17.94 % | 4.21 % |
| Gross Profit | NA | % | % |
| EBITDA | NA | 52.56 % | 12.99 % |
| Net Profit | NA | 65.12 % | 13.25 % |
| EPS | 0 | 65.07 % | NA |
CORONA - Stability Highlights
Stability Analysis
Tsr Stability Index - Excellent Score of 90.62
Paid More Than 50% of Debt, Heading towards debt free
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|
| Debt to Equity Ratio | 0.0264 | -81.08 % | 0 | |
| Cash Ratio | 0.289 | -7.27 % | ||
| Quick Ratio | 0.874 | 2.28 % | 0 | |
| Shareholders Equity | 65.21 | 12.74 % | ||
| Debt to EBITDA | 0.065 | -84.35 % |
Historical Valuation Ratios of CORONA Remedies Limited
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of CORONA Remedies Limited
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of CORONA Remedies Limited
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of CORONA Remedies Limited
Historical Solvency Ratios
Loading ...